Insights into prescribing patterns for antidepressants: an evidence-based analysis.

BACKGROUND

Antidepressants are a primary treatment for depression, yet prescribing them poses significant challenges due to the absence of clear guidelines for selecting the most suitable option for individual patients. This study aimed to analyze prescribing patterns for antidepressants across healthcare providers, including physicians, physician assistants, nurse practitioners, and pharmacists, to better understand the complex factors influencing these patterns in the management of depression.

METHODS

Least Absolute Shrinkage and Selection Operator (LASSO) regression was employed to identify variables that explained the variation in the prescribed antidepressants, utilizing a large number of claims. Models were created to identify the prescription patterns of the 14 most common antidepressants, including amitriptyline, bupropion, citalopram, desvenlafaxine, doxepin, duloxetine, escitalopram, fluoxetine, mirtazapine, nortriptyline, paroxetine, sertraline, trazodone, and venlafaxine. The accuracy of predictions was measured through the Area under the Receiver Operating Curve (AROC).

RESULTS

Our analysis revealed several key factors influencing prescribing patterns, including patients' comorbidities, previous medications, age, and gender. A history of high antidepressant use (four or more prior medications) was the most common factor across antidepressants. Age influenced prescribing patterns, with mirtazapine and trazodone more frequent among older patients, while fluoxetine and sertraline were more common in younger individuals. Condition-specific factors included trazodone for insomnia, and amitriptyline or nortriptyline for headaches. Paroxetine, venlafaxine, and sertraline more often prescribed to females, while bupropion and doxepin were commonly prescribed for patients with tobacco use disorder and opioid dependence. Predictive factors per medicine ranged from 51 (doxepin) to 168 (citalopram), with cross-validated AROC scores averaging 76.3%.

CONCLUSIONS

Our findings provide valuable insights into the nuanced factors that shape evidence-based antidepressant prescribing practices, offering a foundation for more personalized, effective depression treatment. Further research is needed to validate these models in other extant databases. These findings contribute to a more comprehensive understanding of antidepressant prescribing practices and have the potential to improve patient outcomes in the management of depression.